# US 2022/0064212 A1 · Hplc free purification of peptides by the use of new capping and capture reagents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0064212 A1
- Document ID: US20220064212A1
- Status: Published application
- Kind: A1
- Application number: 17/419,073
- Filed: 2020-01-03
- Published: 2022-03-03
- Earliest claimed: 2019-01-07
- Assignees: Roche Diagnostics Operations, Inc.
- Applicants: Roche Diagnostics Operations, Inc.
- Inventors: Frank BERGMANN; Sebastian Johannes POMPLUN
- Web page: https://patentgrep.com/patent/US20220064212A1

## CPC

- C07K 1/063: {for alpha-amino functions}
- C07K 1/20: Partition-, reverse-phase or hydrophobic interaction chromatography
- C07K 1/04: on carriers {(C07K1/003, C07K1/006 take precedence)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present disclosure relates to the use of a capping and capture reagent in solid phase peptide synthesis. The present disclosure further relates to a method of solid phase peptide synthesis, wherein a capping and capture reagent according to the present disclosure is used. The present disclosure further relates to a method for purification of a (full-length) synthetic peptide via use of a capping and capture reagent according to the present disclosure. The present disclosure also relates to a kit comprising a capping and capture reagent according to the present disclosure and an amino oxy resin or a hydrazine resin and the use of the kit.

## Claims

### Claim 1

Use of a capping and capture (cap-capt) reagent comprising a capping moiety and a capture moiety in solid phase peptide synthesis, wherein said capping moiety is a carboxylic acid or an activated carboxylic acid and wherein said capture moiety is a protected carbonyl group.

### Claim 2 (depends on 1)

Use of a capping and capture reagent according to claim 1, wherein the capping and capture (cap-capt) reagent comprises one capping moiety and one capture moiety.

### Claim 3 (depends on 1)

Use of a capping and capture reagent according to claim 1, wherein the capping and capture reagent has Formula (I):
wherein
R1 is hydrogen or an optionally substituted alkyl,
R2 is OR5 or a halogen,
each R3 and R4 is independently an optionally substituted alkyl, or form together with the oxygen atoms to which they are attached an optionally substituted 5-membered or 6-membered ring,
R5 is selected from H, anhydride, succinimide, benzotriazole, pentafluorphenyl, and
and
n is independently 0, 1, 2, 3 or 4.

### Claim 4 (depends on 1)

Use of a capping and capture reagent according to claim 1, wherein the capping and capture reagent is selected from the group consisting of:
wherein
R6, R7, R8 and R9 are each independently selected from hydrogen and alkyl and
R10 is optionally substituted alkyl.

### Claim 5 (depends on 4)

Use of a capping and capture reagent according to claim 4, wherein R6, R7, R8 and R9 are each independently selected from hydrogen and C1-C3 alkyl, and R10 is methyl or ethyl.

### Claim 6 (depends on 1)

Use of a capping and capture reagent according to claim 1, wherein R1 is independently hydrogen, methyl or ethyl.

### Claim 7 (depends on 1)

Use of a capping and capture reagent according to claim 1, wherein R2 is independently selected from the group consisting of O-succinimide, O-pentafluorophenyl, O-benzotriazole, anhydride and

### Claim 8 (depends on 1)

Use of a capping and capture reagent according to claim 1, wherein the capping and capture reagent is selected from

### Claim 9 (depends on 1)

A method for solid phase peptide synthesis (SPPS) wherein individual amino acids are coupled to each other via Fmoc-chemistry and, wherein after at least one coupling step a capping and capture reagent according to claim 1 is used for capping a failure peptide sequence.

### Claim 10 (depends on 9)

Method according to claim 9, wherein the capping moiety of the capping and capture reagent is a carboxylic acid, further comprising the step of: activating the capping moiety, thus preparing an activated carboxylic acid with an activating agent, wherein the activating agent corresponds to the activating agent of Fmoc-chemistry.

### Claim 11 (depends on 9)

A method for purification of a (full-length) synthetic peptide comprising the steps of:
performing a solid phase peptide synthesis according to claim 9,
cleaving the compounds thus synthesized from the solid phase,
deprotecting the capture moiety, and
binding the deprotected capture moiety to a solid resin support thereby binding the at least one failure peptide sequence to the solid resin support and
separating the full-length synthetic peptide from the solid resin support comprising the failure peptide.

### Claim 12 (depends on 11)

Method according to claim 11, wherein the solid resin support is an amino oxy resin, or hydrazine resin.

### Claim 13 (depends on 11)

Method according to claim 11, wherein the separating of the full-length peptide from the solid resin support comprising the failure peptide is carried out by centrifugation or by filtration.

### Claim 14 (depends on 1)

Kit comprising at least one capping and capture reagent according to claim 1 and at least one amino oxy resin, or hydrazine resin.

### Claim 15 (depends on 14)

Use of a kit according to claim 14 for purification of compounds synthesized on a solid support, preferably for the purification of peptides.
